Fig. 1From: bFGF could be a biomarker of malignancy in RS3PE syndrome: an ambispective single-center cohort analysis of 51 patientsROC curve for bFGF in predicting malignancy in patients with RS3PE. ROC receiver operating characteristic, bFGF basic fibroblast growth factor, RS3PE remitting seronegative symmetrical synovitis with pitting edemaBack to article page